Nitroheterocyclic drugs with broad spectrum activity

Area of Science:

• Pharmacology
• Infectious Diseases
• Medicinal Chemistry

Background:

• Nitroheterocyclic compounds, specifically 5- and 2-nitroimidazoles and 5-nitrofurans, possess significant biological activity.
• These compounds are crucial therapeutic agents for treating various protozoan and anaerobic bacterial infections in both humans and animals.

Purpose of the Study:

• To present the current therapeutic status of nitroheterocyclic compounds.
• To characterize key drugs including benznidazole, furazolidone, metronidazole, and others.
• To detail their chemical, chemotherapeutic, toxicological, pharmacokinetic, and pharmacological properties.

Main Methods:

• Review of existing literature on nitroheterocyclic compounds.
• Characterization of selected drugs based on their properties.
• Analysis of mechanisms of action and resistance patterns.

Main Results:

• The review covers the therapeutic applications of nitroheterocyclic drugs against giardiasis, trichomoniasis, balantidiasis, histomoniasis, and amebiasis.
• Detailed pharmacological profiles of ten relevant drugs are provided.
• Information on drug resistance in parasitic protozoa is included.

Conclusions:

• Nitroheterocyclic compounds remain vital in treating a range of parasitic and bacterial infections.
• Understanding their diverse properties is essential for effective therapeutic use.
• Further research into mechanisms and resistance is warranted for optimizing treatment strategies.